 | Up a level |
de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; ... (2023). Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial. ESMO open, 8(1), p. 100772. BMJ 10.1016/j.esmoop.2022.100772
Lambertini, M; Peccatori, F A; Demeestere, I; Amant, F; Wyns, C; Stukenborg, J-B; Paluch-Shimon, S; Halaska, M J; Uzan, C; Meissner, J; von Wolff, M; Anderson, R A; Jordan, K (2020). Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines. Annals of oncology, 31(12), pp. 1664-1678. Elsevier 10.1016/j.annonc.2020.09.006
